Over 10 years ago, the Canadian government approved Botox(type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles.
Comment Reply
Over 10 years ago, the Canadian government approved Botox(type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles.
April 29, 2009 - 7:10amThis Comment
Reply